---
layout: post
title: ---
excerpt_separator: <!--more-->
---


<!--more-->

---
layout: post
title: ---
excerpt_separator: <!--more-->
---


<!--more-->

---
layout: post
title: ---
excerpt_separator: <!--more-->
---


<!--more-->

---
layout: post
title: # 四十年来首个针对子宫内膜异位症的药物即将问世，这标志着科技与科学的进步。


# 四十年来首例子宫内膜异位症药物即将面世|科技与科学。
excerpt_separator: <!--more-->
---


<!--more-->

# 四十年来首例子宫内膜异位症药物即将面世|科技与科学。


# The first endometriosis drug in four decades is on the horizon | Science & technology

![image](https://images.weserv.nl/?url=www.economist.com/img/b/1280/720/90/media-assets/image/20240210_STD001.jpg)

<div></div><p><span>I</span><small>n 1690 Daniel Schrön</small>, a German physician, described a patient with “ulcers” throughout her peritoneum, bladder, intestines, uterus and cervix. It was long thought to be the first documented appearance in medical literature of endometriosis, a painful and debilitating gynaecological condition that today affects as many as 190m women worldwide.</p>

1690年，德国医生丹尼尔·施龙（Daniel Schrön）描述了一位患者的病情。她的腹膜、膀胱、肠道、子宫和宫颈布满了“溃疡”。长期以来，人们认为这是医学文献中首次记载的子宫内膜异位症案例。这是一种痛苦且影响生育能力的妇科疾病，如今全球大约有19亿女性深受其困扰。




<p>Uteruses are lined with the endometrium, a layer of tissue that thickens during a menstrual cycle. If a fertilised egg does not become implanted, the lining thins and is shed as a period. If endometrial tissue grows abnormally outside the uterus, however, it can cause havoc. In extreme cases of endometriosis, adhesions can “bind” a woman’s organs together—from ovaries to bladder to bowels—and freeze them in place. Milder cases come with severe pain, heavy menstruation, inflammation and scar tissue caused by internal bleeding, fatigue and infertility. There is no known cure, and treatment focuses on controlling symptoms, normally through some combination of hormonal birth control, pain relief or surgery.</p>

子宫内膜由一层称为内膜的组织覆盖，这个组织在月经周期中会增厚。如果受精卵未能植入子宫壁，内膜就会变薄并随着经期被排出体外。然而，如果子宫内膜组织异常生长超出子宫范围，它就可能引发一系列问题。在极端情况下，即子宫内膜异位症严重时，粘连可以“连接”女性的器官——从卵巢到膀胱再到肠道——并将它们固定在一起无法正常活动。较轻的症状则伴随着剧烈疼痛、月经量多、炎症以及由于内部出血导致的疤痕组织，这些都会带来疲劳和不孕等问题。目前尚无已知的治愈方法，治疗方法主要集中在控制症状上，通常会结合激素避孕法、止痛药或手术来实现这一目标。


<div><div><div id="econ-1"></div></div></div><p>The World Health Organisation estimates that endometriosis affects around one in ten women during their lifetime—roughly the same as the proportion of the global population with diabetes. But whereas doctors understand why diabetes occurs and how to treat it, their understanding of endometriosis is languishing “30 to 40 years” behind, according to Andrew Horne, a professor of gynaecology and reproductive sciences at the University of Edinburgh and president-elect of the World Endometriosis Society. He blames it on a lack of research and awareness, driven by funding shortages. </p>

世界卫生组织估计，在女性的一生中，子宫内膜异位症大约影响着十分之一的女性——这大致相当于全球人口中糖尿病患者的比例。然而，虽然医生明白为什么糖尿病会发生以及如何治疗它，但他们对子宫内膜异位症的理解却“落后30到40年”，据爱丁堡大学妇科和生殖科学教授、世界内膜异位症学会候任主席安德鲁·霍恩（Andrew Horne）称。他将这种落后归咎于缺乏研究和认识，这主要是由于资金短缺造成的。


<p>Things are starting to change. A clinical trial of the first non-hormonal, non-surgical treatment for endometriosis, started in 2023 in Scotland, is showing promising results. Dr Horne says that the trial, which he co-leads, grew out of closer examinations of how endometriosis lesions form. By taking samples from patients during diagnostic laparoscopies, his team found that those with peritoneal endometriosis—meaning disease on the lining of the pelvic cavity, which represents around 80% of cases—had significantly higher levels of a chemical called lactate in their pelvises than those without. </p>

情况正在发生变化。2023年在苏格兰开始的一项关于子宫内膜异位症的第一个非激素、非手术治疗的临床试验，显示出令人鼓舞的结果。霍恩博士说，他共同领导的这项试验源于对子宫内膜异位症病变如何形成更深入的研究。通过在诊断腹腔镜手术期间从患者那里取样，他的团队发现那些患有盆腔内膜异位症（即疾病发生在盆腔内的粘膜上，约占80%的病例）的人，与没有这种疾病的相比，她们的骨盆中有显著更高的乳酸含量。
:
:

<p>Lactate is produced when the body breaks down glucose (and is also the cause of the uncomfortable stitches that can suddenly strike runners). Its increased presence, the researchers reckoned, suggested a hand in the development of endometriosis lesions, possibly similar to the role lactate plays in helping cancer cells proliferate. Scientists then looked for a drug that had already been tested in cancer patients, settling eventually on dichloroacetate (<small>DCA</small>). This is also used to treat rare types of metabolic disorders in children in which excess lactic acid builds up in the blood.</p>

乳酸是在身体分解葡萄糖（也是跑步者突然感到不适的原因）时产生的。研究人员认为，乳酸含量的增加可能在子宫内膜异位症病变的发展中发挥了作用，类似于乳酸帮助癌细胞增殖的作用。

科学家们随后寻找已经在癌症患者中测试过的药物，最终选择了二氯乙酸（DCA）。它也被用于治疗儿童中罕见类型的代谢障碍疾病，其中血液中过量的乳酸积累。

因此，研究人员通过选择已知具有抗癌作用的药物，并考虑其对代谢异常的影响，来研究可能与子宫内膜异位症相关的机制。


<h2>Lead me to your door</h2>

引领我至你的门前


<p>A small group of human patients who were treated with <small>DCA</small> reported lessened pain and better quality of life. A trial with a larger cohort, plus a placebo arm, is next. If the drug is approved, which may be possible within the next five to seven years, <small>DCA</small> will be the first new endometriosis treatment discovered in four decades.</p>

一小群接受DCA治疗的人类患者报告称疼痛减轻，生活质量提高。接下来将进行一项包含更大样本量的试验，以及一个安慰剂臂。如果该药物获得批准，这可能在未来五到七年之内实现，那么DCA将成为四十年来发现的第一个新的子宫内膜异位症治疗方法。


<p>“There is still an issue—and I hate to say it—with issues that only affect women,” Dr Horne says. That observation is borne out elsewhere. A report released last month by McKinsey, a consultancy, concluded that “systematic lack of disease understanding” led to a loss of 40m-45m disability-adjusted life years for women annually, amounting to four lost days of “healthy life” per year per woman worldwide. </p>

“对于只影响女性的问题，仍然存在问题。”霍恩博士说。这一观察在其他地方也得到了证实。咨询公司麦肯锡（McKinsey）上月发布的一份报告显示，“对疾病理解的系统性缺乏”导致每年有大约4000万至4500万女性丧失调整为残疾年限的健康生活年数，相当于每年全球每位女性损失四天“健康生活”。


<div><div><div id="econ-2"></div></div></div><p>In terms of endometriosis, lack of medical understanding impedes diagnosis as well as treatment. A study conducted by academics at Manchester Metropolitan University, published in January in the <i>Journal of Health Communication, </i>interviewed British women at different stages of obtaining a diagnosis, which takes ten years on average. Many respondents said their symptoms were initially (and sometimes repeatedly) dismissed as either normal period pains, the result of lifestyle factors such as being overweight, or as psychological. One reason that diagnosing endometriosis is such a drawn-out, gruelling process is that it almost always requires surgery: most lesions can be found only by inserting a camera (though those which cause cysts generally show up on scans). To speed things up, scientists have therefore been looking for “biomarkers”—the signatures of proteins or processes related to a disease, which show up somewhere easy to test, like a patient’s blood or urine.</p>

关于子宫内膜异位症，缺乏医学理解妨碍了诊断和治疗。曼彻斯特都会大学的学者们进行的一项研究，于一月份发表在《健康传播》期刊上。该研究采访了英国女性，在获得诊断的不同阶段，诊断过程通常平均需要十年时间。

许多受访者表示，她们的症状最初（有时甚至是反复）被忽视为正常的经期疼痛、生活方式因素如超重的结果，或者仅仅是心理上的问题。子宫内膜异位症的确诊过程为何如此漫长和艰辛的一个原因是，它几乎总是需要手术：大多数病灶只能通过插入摄像头来发现（不过导致囊肿的那些通常会在扫描中显现）。为了加快进程，科学家们一直在寻找“生物标志物”——与疾病相关的蛋白质或过程的签名，在患者血液或尿液等易于测试的地方出现。

全文翻译完。


<p>Ziwig, a French pharmaceutical firm, claims to have found such a solution for endometriosis. Its test looks for specific micro<small>RNA</small>s—tiny strands of genetic material—which, one study shows, appear in the saliva of women with existing endometriosis diagnoses. In January the health-care authority of France approved a pilot scheme to assess the effectiveness of Ziwig’s “Endotest” ahead of a possible rollout. In 2022 Emmanuel Macron, the country’s president, declared endometriosis “society’s problem” and made improving treatment a national priority.</p>

法国制药公司Ziwig声称已经找到了治疗子宫内膜异位症的解决方案。他们的测试方法是寻找特定的microRNA（微小的基因物质链）——研究显示，这些microRNA会在已确诊子宫内膜异位症女性的唾液中出现。

今年1月，法国卫生保健机构批准了一个试点项目，旨在评估Ziwig的“Endotest”在可能的推广之前的有效性。 

2022年，法国总统Emmanuel Macron将子宫内膜异位症称为“社会问题”，并将改善治疗作为国家优先事项。


<p>These developments do not mean that the problem of diagnosis is solved, warns Dr Horne, who believes that more research is required to test how endometriosis biomarkers appear in larger, more disparate populations. But, after years of relative inaction, he now sees endometriosis research as “a fast-moving field” at last. “I think I feel confident,” he says. <span>■</span></p>

这些进展并不意味着诊断问题已经得到解决，霍恩博士警告说。他认为，还需要更多的研究来测试子宫内膜异位症生物标志物在更大、更多元化的人群中的表现。但经过多年的相对无所作为后，他现在看到子宫内膜异位症研究“终于成为了一个快速发展的领域”。他说：“我觉得自己有信心。”■


<p><i>Curious about the world? To enjoy our mind-expanding science coverage, sign up to <a href="https://www.economist.com/newsletters/simply-science">Simply Science</a>, our weekly subscriber-only newsletter.</i></p>

对世界充满好奇？想要了解更多令人惊叹的科学资讯吗？订阅我们的《简单科学》（Simply Science），这是一份每周发送、仅限订阅者的新闻通讯。